COVID
Surveillance of COVID-19 in Cameroon: Implications for policymakers and the healthcare system
Submitted: 11 April 2024 | Published: 31 December 2021
About the author(s)
Bruno Bonnechère, Department of Psychiatry and Behavioural and Clinical Neurosciences, University of Cambridge, Cambridge, United KingdomOsman Sankoh, Statistics Sierra Leone, Freetown, Sierra Leone; Njala University, Njala, Sierra Leone; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; 5Heidelberg Institute of Global Health, University of Heidelberg Medical School, Heidelberg, Germany
Sékou Samadoulougou, Evaluation Platform on Obesity Prevention, Quebec Heart and Lung Institute Research Center, Quebec City; Centre for Research on Planning and Development (CRAD), Laval University, Quebec, Canada
Jean Cyr Yombi, Department of Infectious diseases, cliniques Universitaires Saint Luc, Institut de Recherches Exp rimentales et Cliniques (IREC), UCLouvain, Bruxelles, Belgium
Fati Kirakoya-Samadoulougou, Centre de Recherche en Epid miologie, Biostatistique et Recherche Clinique, Ecole de Sant Publique, Universit Libre de Bruxelles (ULB), Bruxelles
Full Text:
PDF (9MB)Abstract
Keywords
Metrics
Total abstract views: 2185Total article views: 405
Crossref Citations
1. Deciphering the Effects of Pterocarpus mildbraedii and Pterocarpus soyauxii Against Sars-CoV-2 and HIV Coinfection through the Integration of ADMET, Network Pharmacology, in silico Molecular Docking, Pharmacophore Analysis and Computational Inhibition of CDK2 and HIV-1 Viral Proteins
Owona Pascal Emmanuel, Mengue Ngadena Yolande Sandrine, Bidingha A. Goufani Ronald, Bilanda Danielle Claude, Ngo Song Maguy Camille, Dzeufiet Djomeni Paul Désiré, Rania Ali El Hadi Mohamed, Maher S. Alwethaynani, Nawal Al-Hoshani, Ammena Y. Binsaleh, Manal F. Elkhadragy, Tariq Aziz
Journal of Computational Biophysics and Chemistry vol: 25 issue: 11 first page: 2855 year: 2026
doi: 10.1142/S2737416526500390
2. Seroprevalence of SARS‐CoV‐2 in 10 Regional Capitals of Cameroon, October–December 2020
Karampreet Sachathep, Yen T. Duong, Giles Reid, Emily Kainne Dokubo, Judith D. Shang, Clement B. Ndongmo, Ekali Gabriel, G. Tharp, Laura Eno Dimite, Adama N'Dir, Gordon Okpu, Francis M. Ogollah, Dubliss Nguafack, Martin C. Ntse, Gili Hrusa, Katherine Yuengling, Megan Tebbenhoff, Essomba René, Ngo Sack Françoise, Naah Tabala Felicity, Marie Claire Okomo, Anne‐Cecile Zoung‐Kanyi Bissek, Tiffany G. Harris
Influenza and Other Respiratory Viruses vol: 18 issue: 4 year: 2024
doi: 10.1111/irv.13267
3. Nanotechnology and COVID-19: Prevention, diagnosis, vaccine, and treatment strategies
Sumeyra Ayan, Kubra Aranci-Ciftci, Fatih Ciftci, Cem B. Ustundag
Frontiers in Materials vol: 9 year: 2023
doi: 10.3389/fmats.2022.1059184
4. Monitoring the impact of Movement Control Order (MCO) in flattening the cummulative daily cases curve of Covid-19 in Malaysia: A generalized logistic growth modeling approach
Nicholas Tze Ping Pang, Assis Kamu, Mohd Amiruddin Mohd Kassim, Chong Mun Ho
Infectious Disease Modelling vol: 6 first page: 898 year: 2021
doi: 10.1016/j.idm.2021.07.004
